Show simple item record

dc.contributor.authorO'Brien, D P
dc.contributor.authorSauvageot, D
dc.contributor.authorOlson, D
dc.contributor.authorSchaeffer, M
dc.contributor.authorHumblet, P
dc.contributor.authorPudjades, M
dc.contributor.authorEllman, T
dc.contributor.authorZachariah, R
dc.contributor.authorSzumilin, E
dc.contributor.authorArnould, L
dc.contributor.authorReid, T
dc.date.accessioned2008-02-14T11:46:31Z
dc.date.available2008-02-14T11:46:31Z
dc.date.issued2007-05-01
dc.identifier.citationTreatment Outcomes Stratified by Baseline Immunological Status Among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings. 2007, 44 (9):1245-8 Clin. Infect. Dis.
dc.identifier.issn1537-6591
dc.identifier.pmid17407046
dc.identifier.doi10.1086/513433
dc.identifier.urihttp://hdl.handle.net/10144/18270
dc.description.abstractA study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86-0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%.
dc.language.isoen
dc.publisherPublished by: Infectious Diseases Society of America
dc.relation.urlhttp://www.journals.uchicago.edu/page/cid/brief.html
dc.rightsArchived on this site with permission and copyright by the Infectious Diseases Society of Americaen_GB
dc.subject.meshAcquired Immunodeficiency Syndrome
dc.subject.meshCD4 Lymphocyte Count
dc.subject.meshChild, Preschool
dc.subject.meshDeveloping Countries
dc.subject.meshDrug Therapy, Combination
dc.subject.meshFemale
dc.subject.meshHealth Resources
dc.subject.meshHumans
dc.subject.meshImmune Tolerance
dc.subject.meshMale
dc.subject.meshProbability
dc.subject.meshReverse Transcriptase Inhibitors
dc.subject.meshSurvival Analysis
dc.subject.meshTreatment Outcome
dc.titleTreatment Outcomes Stratified by Baseline Immunological Status Among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings.
dc.contributor.departmentAIDS Working Group, Médecins Sans Frontières, Paris, France. daniel.obrien@amsterdam.msf.org
dc.identifier.journalClinical Infectious Diseases
refterms.dateFOA2019-03-04T09:19:48Z
html.description.abstractA study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86-0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%.


Files in this item

Thumbnail
Name:
CID Dan OBrien Oct 1.pdf
Size:
79.74Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record